Private company
Symphogen
Symphogen is a biotechnology company located in Copenhagen, Denmark that develops protein drugs based on recombinant monoclonal antibody mixtures. These drugs are different from the polyclonal antibodies, as each antibody in the mixture is produced from one carefully selected clone.2 It was founded in 2000.1 Wikipedia text CC BY-SA 4.0
Last updated Oct 20, 2026.
Overview
- HeadquartersBallerup1
- Websitewww.symphogen.com
- Legal formaktieselskab1
- LEI549300QODY3R3ADBHG913
- StatusActive3
- LEI statusLapsed (not renewed)3
- Registered addressPederstrupvej 93, 2750 Ballerup, Denmark3
- Registered withDanish Business Authority, 100132673
See how the biggest companies compare on our leaderboards
.jpg){kind=link}
Symphogen is a biotechnology company located in Copenhagen, Denmark that develops protein drugs based on recombinant monoclonal antibody mixtures. These drugs are different from the polyclonal antibodies, as each antibody in the mixture is produced from one carefully selected clone.2
Leadership
Who has led Symphogen, and when. Pick a name to see everywhere that person has worked.
Board members and other officers (1)
- Board memberMikkel W Pedersen Jan 20, 2012 to Oct 30, 20181
Subsidiaries and ownership
Owners
From Wikidata.1
Timeline
- 2000Founded Founded1
Links
- Websitewww.symphogen.com1
- WikipediaSymphogen
- WikidataQ7661403
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataSymphogen on Wikidata
- 2WikipediaSymphogen on Wikipedia
- 3
- 4Wikimedia CommonsSymphogen photo by Johan Wessman / News Oresund, CC BY 2.0